HighTide Therapeutics (Hong Kong) Limited
5 clinical trials · Sponsor
◉ Watch HighTide Therapeutics (Hong Kong) Limited
| Record | Firm | Date |
|---|---|---|
| HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes (NCT05623189) | HighTide Therapeutics (Hong Kong) Limited | 2022-12-27 |
| A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) (NCT03678480) | HighTide Therapeutics (Hong Kong) Limited | 2021-03-01 |
| A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia (NCT03381287) | HighTide Therapeutics (Hong Kong) Limited | 2018-04-13 |
Track HighTide Therapeutics (Hong Kong) Limited automatically
Every clearance here is in the API, with alerts when new ones post.